GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 11, 2024 |
PDB ID | UniProt ID ▼ | Title | Descriptor |
---|---|---|---|
2FIR | P08709 | Crystal structure of DFPR-VIIa/sTF | Coagulation factor VII Light chain (E.C.3.4.21.21), Coagulation factor VII Heavy Chain (EC 3.4.21.21), Tissue factor |
2PUQ | P08709 | Crystal structure of active site inhibited coagulation factor VIIA in complex with soluble tissue factor | |
2ZP0 | P08709 | Human factor viia-tissue factor complexed with benzylsulfonamide-D-ile-gln-P-aminobenzamidine | |
2ZWL | P08709 | Human factor viia-tissue factor complexed with highly selective peptide inhibitor | |
2ZZU | P08709 | Human Factor VIIA-Tissue Factor Complexed with ethylsulfonamide-D-5-(3-carboxybenzyloxy)-Trp-Gln-p-aminobenzamidine | |
3ELA | P08709 | Crystal structure of active site inhibited coagulation factor VIIA mutant in complex with soluble tissue factor | |
3TH2 | P08709 | Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+ | |
3TH3 | P08709 | Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+ | |
3TH4 | P08709 | Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+ | |
4IBL | P08709 | Rubidium Sites in Blood Coagulation Factor VIIa | |
4YLQ | P08709 | Crystal Structure of a FVIIa-Trypsin Chimera (FT) in Complex with Soluble Tissue Factor | |
4Z6A | P08709 | Crystal Structure of a FVIIa-Trypsin Chimera (YT) in Complex with Soluble Tissue Factor | |
4ZMA | P08709 | Crystal Structure of a FVIIa-Trypsin Chimera (ST) in Complex with Soluble Tissue Factor | |
5L0S | P08709 | human POGLUT1 in complex with Factor VII EGF1 and UDP | |
6R2W | P08709 | Crystal structure of the super-active FVIIa variant VYT in complex with tissue factor | |
8CN9 | P08709 | Factor VII binding Fab of the bispecific antibody HMB-001 in complex with Factor VII | |
8UUD | P08709 | BCX2627 complexed with human FVIIa and soluble Tissue Factor. | |
8QQ6 | P08709 | CRYSTAL STRUCTURE OF FVIIA IN COMPLEX WITH A BENZAMIDINE-BASED INHIBITOR | |
8QOD | P08709 | CRYSTAL STRUCTURE OF FVIIA IN COMPLEX WITH A BENZAMIDINE-BASED INHIBITOR | |
8JDK | P08708 | Structure of the Human cytoplasmic Ribosome with human tRNA Asp(ManQ34) and mRNA(GAU) | |
8JDL | P08708 | Structure of the Human cytoplasmic Ribosome with human tRNA Tyr(GalQ34) and mRNA(UAU) (non-rotated state) | |
8JDM | P08708 | Structure of the Human cytoplasmic Ribosome with human tRNA Tyr(GalQ34) and mRNA(UAU) (rotated state) | |
5UV8 | P08700 | Interleukin-3 Receptor Complex | |
5UWC | P08700 | Cytokine-receptor complex | |
6NMY | P08700 | A Cytokine-receptor complex | |
6YXK | P08670 | Crystal structure of ACPA 3F3 in complex with cit-vimentin 59-74 | |
4MCY | P08670 | Immune Receptor | |
4MCZ | P08670 | Immune Receptor | |
4MD0 | P08670 | Immune Receptor | |
4MD5 | P08670 | Immune Receptor | |
4MDI | P08670 | Immune Receptor | |
4MDJ | P08670 | Immune Receptor | |
8TRQ | P08670 | T cell recognition of citrullinated vimentin peptide presented by HLA-DR4 | |
8TRR | P08670 | T cell recognition of citrullinated vimentin peptide presented by HLA-DR4 | |
8T5C | P08669 | Lassa GPC Trimer in complex with Fab 8.11G and nanobody D5 | |
8TYC | P08669 | Lassa GPC (strain Josiah) bound to rabbit polyclonal base-targeting antibody Base-1 | |
8TYE | P08669 | Lassa GPC (strain Josiah) bound to rabbit polyclonal fusion-peptide-targeting antibody FP-1 | |
6P95 | P08669 | Structure of Lassa virus glycoprotein in complex with Fab 25.6A | |
7S8H | P08669 | Structure of Lassa virus glycoprotein bound to Fab 18.5C and Fab 36.1F | |
7TYV | P08669 | Structure of Lassa Virus glycoprotein (Josiah) bound to Fab 25.10C | |
5VK2 | P08669 | Structural basis for antibody-mediated neutralization of Lassa virus | |
8EJD | P08669 | Structure of lineage IV Lassa virus glycoprotein complex (strain Josiah) | |
8EJH | P08669 | Lassa virus glycoprotein complex (Josiah) bound to 12.1F Fab | |
8EJI | P08669 | Lassa virus glycoprotein complex (Josiah) bound to 19.7E Fab | |
5FT2 | P08669 | Sub-tomogram averaging of Lassa virus glycoprotein spike from virus- like particles at pH 5 | |
7UOT | P08669 | Native Lassa glycoprotein in complex with neutralizing antibodies 8.9F and 37.2D | |
7UOV | P08669 | Native Lassa glycoprotein in complex with neutralizing antibodies 12.1F and 37.2D | |
7PVD | P08669 | Structure of the membrane soluble spike complex from the Lassa virus in a C1-symmetric map focused on the ectodomain | |
9CJ7 | P08669 | Lineage IV Lassa virus glycoprotein (Josiah) in complex with monoclonal antibody 8.9F | |
9CJ8 | P08669 | Lineage IV Lassa virus glycoprotein (Josiah) in complex with rabbit polyclonal antibody (LAVA01-like epitope) |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024